Literature DB >> 30269243

Authors' Reply to Cohen et al.'s Comment on "Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database".

Julie Mouchet1, Bernard Bégaud2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30269243     DOI： 10.1007/s40264-018-0734-3

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  4 in total

1.  Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.

Authors:  A Fourrier; B Bégaud; A Alpérovitch; M H Verdier-Taillefer; E Touzé; N Decker; J L Imbs
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

2.  A case-control study of serious autoimmune adverse events following hepatitis B immunization.

Authors:  David A Geier; Mark R Geier
Journal:  Autoimmunity       Date:  2005-06       Impact factor: 2.815

Review 3.  Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.

Authors:  Julie Mouchet; Francesco Salvo; Emanuel Raschi; Elisabetta Poluzzi; Ippazio Cosimo Antonazzo; Fabrizio De Ponti; Bernard Bégaud
Journal:  Vaccine       Date:  2018-02-15       Impact factor: 3.641

4.  Comment on "Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database".

Authors:  Carine Cohen; Annick Houdeau; Alena Khromava
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.